Non-CE Product Theater: Expanding Options for Patients with HER2-Low mBC

Not a CE-certified activity. Presented by Daiichi Sankyo, Inc. and AstraZeneca.

The information and views expressed in this presentation are solely that of the presenter, and do not necessarily reflect the position and policies of NCCN.

NCCN makes no warranties of any kind whatsoever regarding their content, use, or application and disclaims any responsibility for their application or use in any way.